Doliver Capital Advisors LP bought a new position in UnitedHealth Group Inc (NYSE:UNH) during the 4th quarter, HoldingsChannel.com reports. The firm bought 4,193 shares of the healthcare conglomerate’s stock, valued at approximately $1,045,000. UnitedHealth Group accounts for 0.5% of Doliver Capital Advisors LP’s investment portfolio, making the stock its 21st biggest holding.
Several other hedge funds also recently modified their holdings of the company. Ipswich Investment Management Co. Inc. purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $40,000. OLD Second National Bank of Aurora raised its holdings in shares of UnitedHealth Group by 70.0% during the 4th quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock worth $42,000 after acquiring an additional 70 shares in the last quarter. Contravisory Investment Management Inc. raised its holdings in shares of UnitedHealth Group by 172.1% during the 4th quarter. Contravisory Investment Management Inc. now owns 185 shares of the healthcare conglomerate’s stock worth $46,000 after acquiring an additional 117 shares in the last quarter. Evolution Wealth Advisors LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at approximately $76,000. Finally, CX Institutional increased its position in shares of UnitedHealth Group by 475.0% during the 4th quarter. CX Institutional now owns 322 shares of the healthcare conglomerate’s stock valued at $80,000 after purchasing an additional 266 shares during the last quarter. 85.42% of the stock is owned by institutional investors.
UNH opened at $269.51 on Thursday. The company has a market capitalization of $258.75 billion, a P/E ratio of 20.92, a PEG ratio of 1.39 and a beta of 0.86. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.73 and a current ratio of 0.73. UnitedHealth Group Inc has a 1-year low of $212.49 and a 1-year high of $287.94.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 15th. The healthcare conglomerate reported $3.28 earnings per share for the quarter, topping analysts’ consensus estimates of $3.20 by $0.08. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The company had revenue of $58.42 billion for the quarter, compared to analyst estimates of $58.01 billion. During the same quarter in the prior year, the company posted $2.59 EPS. The business’s revenue for the quarter was up 12.2% compared to the same quarter last year. As a group, equities research analysts forecast that UnitedHealth Group Inc will post 14.62 earnings per share for the current fiscal year.
In other news, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction dated Thursday, January 17th. The stock was sold at an average price of $260.55, for a total transaction of $3,908,250.00. Following the completion of the sale, the director now directly owns 193,872 shares in the company, valued at $50,513,349.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, January 22nd. The shares were sold at an average price of $266.61, for a total value of $1,333,050.00. Following the sale, the director now owns 77,702 shares of the company’s stock, valued at $20,716,130.22. The disclosure for this sale can be found here. Insiders sold 26,090 shares of company stock worth $6,956,975 over the last three months. 0.87% of the stock is currently owned by corporate insiders.
Several equities analysts have commented on UNH shares. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, November 21st. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $279.00 price objective for the company in a research note on Saturday, January 5th. Argus upped their price objective on UnitedHealth Group from $285.00 to $295.00 and gave the stock a “buy” rating in a research note on Monday, December 17th. Raymond James set a $310.00 price target on UnitedHealth Group and gave the company a “buy” rating in a research note on Wednesday, November 28th. Finally, BMO Capital Markets set a $310.00 price target on UnitedHealth Group and gave the company a “buy” rating in a research note on Tuesday, November 27th. One investment analyst has rated the stock with a hold rating and twenty-two have given a buy rating to the company’s stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $297.80.
ILLEGAL ACTIVITY NOTICE: “Doliver Capital Advisors LP Acquires New Holdings in UnitedHealth Group Inc (UNH)” was published by Macon Daily and is the sole property of of Macon Daily. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The original version of this piece of content can be viewed at https://macondaily.com/2019/02/21/doliver-capital-advisors-lp-acquires-new-holdings-in-unitedhealth-group-inc-unh.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: What is Cost of Capital?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.